Department of Clinical Genetics, Dr. Molewaterplein, 50, Rotterdam, The Netherlands.
Dev Biol. 2013 Oct 1;382(1):320-9. doi: 10.1016/j.ydbio.2013.05.019. Epub 2013 May 23.
Finding genes for complex diseases has been the goal of many genetic studies. Most of these studies have been successful by searching for genes and mutations in rare familial cases, by screening candidate genes and by performing genome wide association studies. However, only a small fraction of the total genetic risk for these complex genetic diseases can be explained by the identified mutations and associated genetic loci. In this review we focus on Hirschsprung disease (HSCR) as an example of a complex genetic disorder. We describe the genes identified in this congenital malformation and postulate that both common 'low penetrant' variants in combination with rare or private 'high penetrant' variants determine the risk on HSCR, and likely, on other complex diseases. We also discuss how new technological advances can be used to gain further insights in the genetic background of complex diseases. Finally, we outline a few steps to develop functional assays in order to determine the involvement of these variants in disease development.
寻找复杂疾病的基因一直是许多遗传研究的目标。这些研究大多数通过在罕见的家族病例中寻找基因和突变、筛选候选基因以及进行全基因组关联研究而取得了成功。然而,通过已鉴定的突变和相关遗传位点只能解释这些复杂遗传疾病总遗传风险的一小部分。在这篇综述中,我们以先天性巨结肠症 (HSCR) 为例,探讨复杂遗传疾病。我们描述了在这种先天性畸形中发现的基因,并推测常见的“低外显率”变异与罕见或个体的“高外显率”变异共同决定了 HSCR 的风险,可能还决定了其他复杂疾病的风险。我们还讨论了如何利用新的技术进步来进一步深入了解复杂疾病的遗传背景。最后,我们概述了一些步骤,以开发功能测定法来确定这些变异在疾病发展中的作用。